<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/41C4BC42-CA41-4DA7-BC0E-A737BE37B4EA"><gtr:id>41C4BC42-CA41-4DA7-BC0E-A737BE37B4EA</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Chambers</gtr:surname><gtr:orcidId>0000-0003-2605-1597</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/96CDE81C-B846-4636-BE59-5E007B06FE91"><gtr:id>96CDE81C-B846-4636-BE59-5E007B06FE91</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:otherNames>Roy</gtr:otherNames><gtr:surname>Tomlinson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0901533"><gtr:id>DF661B6F-6003-477A-9DFF-D4127C18BECC</gtr:id><gtr:title>Transcription factor dynamics in control of pluripotent cell function and identity</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901533</gtr:grantReference><gtr:abstractText>Stem cells attract considerable attention because of their potential to repair damaged or exhausted tissue in patients. There are two properties that define stem cells and that account for their potential utility. First, stem cells can make identical copies of themselves and can do this indefinitely, a process we call self-renewal. Second, stem cells can change their properties and become a specialised type of cell that carries out a particular function in our bodies. Within an organism these two properties of self-renewal and specialisation must be balanced. If too many cells specialise, then the stem cell population may run out. If too many cells self-renew, there may be an insufficient supply of specialised cells to maintain an organisms functionality. How does an organism meet these demands upon its stem cell population? We believe we have uncovered an explanation and want to explore the detailed mechanisms behind our observations. We study a type of stem cell called an embryonic stem (or ES) cell. We study mouse ES cells because they are the most tractable experimentally. 
 
We found that all cells in an ES cell population are not the same; some have a greater likelihood of specialising and others a greater likelihood of self-renewing. Unexpectedly we found that these two states could interconvert and the cells that were more likely to specialise could still self-renew and move back into a more niave state. Crucially we were able to determine that these two states could be distinguished by the presence or absence of a particular gene regulator, Nanog. 

In the proposed work, we will ask how Nanog interacts with other gene regulators throughout the genome to turn genes on or off. We will identify genes that carry out the functions of Nanog. A major part of our work will be to determine the mechanisms that switch the Nanog gene on and off and that are therefore central to the function of the stem cell. We will relate our studies to stem cells from more mature embryos and test the relevance of our findings to the intact embryo.

Our studies will deliver a deeper understanding of the switches controlling the behaviour of ES cells. Not only will this be important in learning how to optimally apply ES cells in potentially therapeutic situations but may provide fundamental insights applicable to all stem cells.</gtr:abstractText><gtr:technicalSummary>We have shown that undifferentiated ES cells fluctuate between states in which they do or do not express the transcription factor Nanog and that these states are differentially responsiveness to differentiation cues. This raises several questions that form the basis of this proposal. Our overarching aim is to examine the function of pluripotency transcription factors at genes that critically modulate self-renewal efficiency. This will allow us to determine how the pluripotent population is compartmentalised into cells that self-renew efficiently and cells that are responsive to differentiation cues. Such knowledge is important because safe application of stem cells for regenerative therapies demands strict control of stem cells, so that their behaviour can be predictably and uniformly directed. We start from the premise that the molecular machinery of distinct pluripotent cell compartments is controlled by transcription factors that direct expression of the appropriate gene set. We will analyse the interdependencies of chromatin binding of pluripotency transcription factors and will identify genes that distinguish between ES cells of high and low self-renewal efficiency. We will determine which of the differentially expressed genes is responsible for the differences in phenotype by modulating the expression of these target genes. We will determine whether enforced expression of pluripotency regulators that control such target genes can complement the self-renewal efficiency of the low-efficiency compartment. We will analyse transcriptional controls operating at the Nanog gene that may influence Nanog heterogeneity and will relate these to chromatin states in Nanog expressing and Nanog non-expressing cells. We will assess single cells to determine the co-ordination between Nanog and other fluctuating genes and will assess the effect of altering transcription factor stability on the dynamics of heterogeneity. We will also extend our studies to epiblast stem cells cultured in vitro to determine whether overlapping mechanisms govern the identity of cells which can readily and quickly be derived from ES cells and will examine hypotheses that arise in the course of the studies to determine the relevance of our findings to cells in the embryo. We anticipate that these studies will lead to a deeper understanding of the mechanisms governing pluripotent cell function and that such knowledge can be used to advance the safe application of pluripotent cells for regenerative medicine.</gtr:technicalSummary><gtr:fund><gtr:end>2014-05-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1046787</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenial Award 2013</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>41A4B3AA-10A6-480D-BE37-39E9AA96A9DC</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centennial award</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>8169466E-3C52-4431-87F5-C173419200FD</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D753037-ECFF-49D4-81B4-31B25E7B6FBC"><gtr:id>5D753037-ECFF-49D4-81B4-31B25E7B6FBC</gtr:id><gtr:title>Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42d5bb3174032da9e3a7df366721fa14"><gtr:id>42d5bb3174032da9e3a7df366721fa14</gtr:id><gtr:otherNames>Festuccia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/74EE6895-AE20-483D-A1D7-7C0F1260BA32"><gtr:id>74EE6895-AE20-483D-A1D7-7C0F1260BA32</gtr:id><gtr:title>The pluripotent genome in three dimensions is shaped around pluripotency factors.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7df1a2225d8329ab6f0fb3688c389e38"><gtr:id>7df1a2225d8329ab6f0fb3688c389e38</gtr:id><gtr:otherNames>de Wit E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B63605BC-67CF-4792-B704-7A7F526C3C33"><gtr:id>B63605BC-67CF-4792-B704-7A7F526C3C33</gtr:id><gtr:title>Stem cell powwow in Squaw Valley.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b3860c30b4f83f7128ac0ad48727bde7"><gtr:id>b3860c30b4f83f7128ac0ad48727bde7</gtr:id><gtr:otherNames>Chambers I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E920A6D4-A372-4E68-B000-4A15A7D6A2A4"><gtr:id>E920A6D4-A372-4E68-B000-4A15A7D6A2A4</gtr:id><gtr:title>Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/79c578e554b46e853450f8cff352b38c"><gtr:id>79c578e554b46e853450f8cff352b38c</gtr:id><gtr:otherNames>Karwacki-Neisius V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/99E26D7C-AE95-4E8C-B659-2852FDDA00BF"><gtr:id>99E26D7C-AE95-4E8C-B659-2852FDDA00BF</gtr:id><gtr:title>OCT4/SOX2-independent Nanog autorepression modulates heterogeneous Nanog gene expression in mouse ES cells.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cefda97756d1af8702ea76cebdb7f092"><gtr:id>cefda97756d1af8702ea76cebdb7f092</gtr:id><gtr:otherNames>Navarro P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/72C94194-EF5E-4810-9D4F-31A8A4FE8FBF"><gtr:id>72C94194-EF5E-4810-9D4F-31A8A4FE8FBF</gtr:id><gtr:title>Transcription factor heterogeneity in pluripotent stem cells: a stochastic advantage.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4dfc02e63ca4ee383f2a14b21cf763b2"><gtr:id>4dfc02e63ca4ee383f2a14b21cf763b2</gtr:id><gtr:otherNames>Torres-Padilla ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/26365CCC-9D5C-4AE6-AB20-53CA57D297C1"><gtr:id>26365CCC-9D5C-4AE6-AB20-53CA57D297C1</gtr:id><gtr:title>A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a19d596e1eea1ed603b17f92d0d4e6a"><gtr:id>4a19d596e1eea1ed603b17f92d0d4e6a</gtr:id><gtr:otherNames>Gagliardi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7444CF6-12C8-4434-9CFB-304CF19F38BE"><gtr:id>D7444CF6-12C8-4434-9CFB-304CF19F38BE</gtr:id><gtr:title>GeneProf data: a resource of curated, integrated and reusable high-throughput genomics experiments.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7cbe22bb9e92144bb1e100dda711910b"><gtr:id>7cbe22bb9e92144bb1e100dda711910b</gtr:id><gtr:otherNames>Halbritter F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA1B8AC1-0623-49D9-B5C1-3840659C8DAE"><gtr:id>AA1B8AC1-0623-49D9-B5C1-3840659C8DAE</gtr:id><gtr:title>The role of pluripotency gene regulatory network components in mediating transitions between pluripotent cell states.</gtr:title><gtr:parentPublicationTitle>Current opinion in genetics &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42d5bb3174032da9e3a7df366721fa14"><gtr:id>42d5bb3174032da9e3a7df366721fa14</gtr:id><gtr:otherNames>Festuccia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-437X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3ACE701-6E51-45B9-A5B8-464D69D8261F"><gtr:id>A3ACE701-6E51-45B9-A5B8-464D69D8261F</gtr:id><gtr:title>Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42d5bb3174032da9e3a7df366721fa14"><gtr:id>42d5bb3174032da9e3a7df366721fa14</gtr:id><gtr:otherNames>Festuccia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15458570-6B11-45CA-A58A-087E06FF70B0"><gtr:id>15458570-6B11-45CA-A58A-087E06FF70B0</gtr:id><gtr:title>GeneProf data: a resource of curated, integrated and reusable high-throughput genomics experiments.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7cbe22bb9e92144bb1e100dda711910b"><gtr:id>7cbe22bb9e92144bb1e100dda711910b</gtr:id><gtr:otherNames>Halbritter F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/982B5BFA-275E-4602-A4D2-E175F01DC5EA"><gtr:id>982B5BFA-275E-4602-A4D2-E175F01DC5EA</gtr:id><gtr:title>A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4a19d596e1eea1ed603b17f92d0d4e6a"><gtr:id>4a19d596e1eea1ed603b17f92d0d4e6a</gtr:id><gtr:otherNames>Gagliardi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39442A31-6162-487D-9B00-B70381444B28"><gtr:id>39442A31-6162-487D-9B00-B70381444B28</gtr:id><gtr:title>Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7a753c8bb16d1830adeb2b6d70bbe265"><gtr:id>7a753c8bb16d1830adeb2b6d70bbe265</gtr:id><gtr:otherNames>Mistri TK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB733B22-3C92-4DE7-8743-24FF3A45DCC9"><gtr:id>FB733B22-3C92-4DE7-8743-24FF3A45DCC9</gtr:id><gtr:title>Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog.</gtr:title><gtr:parentPublicationTitle>Cell stem cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/79c578e554b46e853450f8cff352b38c"><gtr:id>79c578e554b46e853450f8cff352b38c</gtr:id><gtr:otherNames>Karwacki-Neisius V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1875-9777</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1DC99CA8-4AD0-4539-87BF-E18BE5457BAA"><gtr:id>1DC99CA8-4AD0-4539-87BF-E18BE5457BAA</gtr:id><gtr:title>Lessons in learning: An effective process for engaging 12- to 14-year-olds in stem cell biology.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/daa53eada0a6345be7a8a6843fea0a4c"><gtr:id>daa53eada0a6345be7a8a6843fea0a4c</gtr:id><gtr:otherNames>Kemp E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92DF0A6F-0FDD-4CDB-BD43-7754F8FBED7B"><gtr:id>92DF0A6F-0FDD-4CDB-BD43-7754F8FBED7B</gtr:id><gtr:title>Quantification of pluripotency transcription factor levels in embryonic stem cells by flow cytometry.</gtr:title><gtr:parentPublicationTitle>Current protocols in stem cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/42d5bb3174032da9e3a7df366721fa14"><gtr:id>42d5bb3174032da9e3a7df366721fa14</gtr:id><gtr:otherNames>Festuccia N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1938-8969</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D2E20A3A-E1CB-41F0-8FB1-AC404FD5EC6D"><gtr:id>D2E20A3A-E1CB-41F0-8FB1-AC404FD5EC6D</gtr:id><gtr:title>The developmental dismantling of pluripotency is reversed by ectopic Oct4 expression.</gtr:title><gtr:parentPublicationTitle>Development (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/484b230d81c945de46a36fdf12ffbd50"><gtr:id>484b230d81c945de46a36fdf12ffbd50</gtr:id><gtr:otherNames>Osorno R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-1991</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901533</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>